"Cyclin T"[nm] - Search Results

Year	Number of Results
1998	8
1999	16
2000	21
2001	15
2002	20
2003	24
2004	14
2005	14
2006	11
2007	13
2008	11
2009	18
2010	21
2011	16
2012	14
2013	17
2014	15
2015	7
2016	10
2017	11
2018	7
2019	7
2020	8
2021	11
2022	11
2023	9
2024	2

1

P-TEFb: The master regulator of transcription elongation.

Fujinaga K, Huang F, Peterlin BM. Fujinaga K, et al. Mol Cell. 2023 Feb 2;83(3):393-403. doi: 10.1016/j.molcel.2022.12.006. Epub 2023 Jan 3. Mol Cell. 2023. PMID: 36599353 Free PMC article. Review.

2

Cyclin T: three forms for different roles in physiological and pathological functions.

De Luca A, De Falco M, Baldi A, Paggi MG. De Luca A, et al. J Cell Physiol. 2003 Feb;194(2):101-7. doi: 10.1002/jcp.10196. J Cell Physiol. 2003. PMID: 12494448 Review.

3

Poly(ADP-ribosylation) of P-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage.

Fu H, Liu R, Jia Z, Li R, Zhu F, Zhu W, Shao Y, Jin Y, Xue Y, Huang J, Luo K, Gao X, Lu H, Zhou Q. Fu H, et al. Nat Cell Biol. 2022 Apr;24(4):513-525. doi: 10.1038/s41556-022-00872-5. Epub 2022 Apr 7. Nat Cell Biol. 2022. PMID: 35393539 Free PMC article.

4

Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II.

Lu H, Yu D, Hansen AS, Ganguly S, Liu R, Heckert A, Darzacq X, Zhou Q. Lu H, et al. Nature. 2018 Jun;558(7709):318-323. doi: 10.1038/s41586-018-0174-3. Epub 2018 May 30. Nature. 2018. PMID: 29849146 Free PMC article.

5

Targeting cyclin-dependent kinase 9 in cancer therapy.

Shen YL, Wang YM, Zhang YX, Ma SJ, Yang LH, Zhao CG, Huang XY. Shen YL, et al. Acta Pharmacol Sin. 2022 Jul;43(7):1633-1645. doi: 10.1038/s41401-021-00796-0. Epub 2021 Nov 22. Acta Pharmacol Sin. 2022. PMID: 34811514 Free PMC article. Review.

6

Cellular control of gene expression by T-type cyclin/CDK9 complexes.

Garriga J, Graña X. Garriga J, et al. Gene. 2004 Aug 4;337:15-23. doi: 10.1016/j.gene.2004.05.007. Gene. 2004. PMID: 15276198 Review.

7

Cyclins that don't cycle--cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size.

Sano M, Schneider MD. Sano M, et al. Cell Cycle. 2003 Mar-Apr;2(2):99-104. Cell Cycle. 2003. PMID: 12695656 Review.

8

Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes.

Chiang K, Sung TL, Rice AP. Chiang K, et al. J Virol. 2012 Mar;86(6):3244-52. doi: 10.1128/JVI.05065-11. Epub 2011 Dec 28. J Virol. 2012. PMID: 22205749 Free PMC article.

9

Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells.

Budhiraja S, Famiglietti M, Bosque A, Planelles V, Rice AP. Budhiraja S, et al. J Virol. 2013 Jan;87(2):1211-20. doi: 10.1128/JVI.02413-12. Epub 2012 Nov 14. J Virol. 2013. PMID: 23152527 Free PMC article.

10

CDK9: A key player in cancer and other diseases.

Franco LC, Morales F, Boffo S, Giordano A. Franco LC, et al. J Cell Biochem. 2018 Feb;119(2):1273-1284. doi: 10.1002/jcb.26293. Epub 2017 Oct 5. J Cell Biochem. 2018. PMID: 28722178 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

327 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Results by year